Epidermal healing in burns: autologous keratinocyte transplantation as a standard procedure: update and perspective

Jiad N Mcheik, Christine Barrault, Guillaume Levard, Franck Morel, François-Xavier Bernard, Jean-Claude Lecron, Jiad N Mcheik, Christine Barrault, Guillaume Levard, Franck Morel, François-Xavier Bernard, Jean-Claude Lecron

Abstract

Background: Treatment of burned patients is a tricky clinical problem not only because of the extent of the physiologic abnormalities but also because of the limited area of normal skin available.

Methods: Literature indexed in the National Center (PubMed) has been reviewed using combinations of key words (burns, children, skin graft, tissue engineering, and keratinocyte grafts). Articles investigating the association between burns and graft therapeutic modalities have been considered. Further literature has been obtained by analysis of references listed in reviewed articles.

Results: Severe burns are conventionally treated with split-thickness skin autografts. However, there are usually not enough skin donor sites. For years, the question of how covering the wound surface became one of the major challenges in clinical research area and several procedures were proposed. The microskin graft is one of the oldest methods to cover extensive burns. This technique of skin expansion is efficient, but results remain inconsistent. An alternative is to graft cultured human epidermal keratinocytes. However, because of several complications and labor-intensive process of preparing grafts, the initial optimism for cultured epithelial autograft has gradually declined. In an effort to solve these drawbacks, isolated epithelial cells from selecting donor site were introduced in skin transplantation.

Conclusions: Cell suspensions transplanted directly to the wound is an attractive process, removing the need for attachment to a membrane before transfer and avoiding one potential source of inefficiency. Choosing an optimal donor site containing cells with high proliferative capacity is essential for graft success in burns.

Conflict of interest statement

Disclosure: The authors have no financial interest to declare in relation to the content of this article. The Article Processing Charge was paid for by the authors.

References

    1. Atiyeh BS, Costagliola M. Cultured epithelial autograft (CEA) in burn treatment: three decades later. Burns. 2007;33:405–413.
    1. Rheinwald JG, Green H. Serial cultivation of strains of human epidermal keratinocytes: the formation of keratinizing colonies from single cells. Cell. 1975;6:331–343.
    1. Green H, Kehinde O, Thomas J. Growth of cultured human epidermal cells into multiple epithelia suitable for grafting. Proc Natl Acad Sci U S A. 1979;76:5665–5668.
    1. Boyce ST. Design principles for composition and performance of cultured skin substitutes. Burns. 2001;27:523–533.
    1. Jones I, Currie L, Martin R. A guide to biological skin substitutes. Br J Plast Surg. 2002;55:185–193.
    1. Gerlach J, Wolf SE, Johnen C. Principles of Regenerative Medicine No. 76. Gerlach J. Elsevier, ed. Burlington, MA: Elsevier/Academic Press; 2008. Innovative regenerative medicine approaches to skin cell-based therapy for patients with burn injuries. pp. 1298–1321.
    1. Gallico GG, III, O’Connor NE, Compton CC, et al. Permanent coverage of large burn wounds with autologous cultured human epithelium. N Engl J Med. 1984;311:448–451.
    1. Green H. Cultured cells for the treatment of disease. Sci Am. 1991;265:96–102.
    1. Jackson DM. The evolution of burn treatment in the last 50 years. Burns. 1991;17:329–334.
    1. Harris PA, Leigh IM, Navsaria HA. Pre-confluent keratinocyte grafting: the future for cultured skin replacements? Burns. 1998;24:591–593.
    1. Boyce ST, Kagan RJ, Meyer NA, et al. The 1999 clinical research award. Cultured skin substitutes combined with Integra artificial skin to replace native skin autograft and allograft for the closure of excised full-thickness burns. J Burn Care Rehabil. 1999;20:453–461.
    1. Chester DL, Balderson DS, Papini RP. A review of keratinocyte delivery to the wound bed. J Burn Care Rehabil. 2004;25:266–275.
    1. Wood FM, Kolybaba ML, Allen P. The use of cultured epithelial autograft in the treatment of major burn injuries: a critical review of the literature. Burns. 2006;32:395–401.
    1. Papini S, Cecchetti D, Campani D, et al. Isolation and clonal analysis of human epidermal keratinocyte stem cells in long-term culture. Stem Cells. 2003;21:481–494.
    1. Fuchs E. Skin stem cells: rising to the surface. J Cell Biol. 2008;180:273–284.
    1. Guenou H, Nissan X, Larcher F, et al. Human embryonic stem-cell derivatives for full reconstruction of the pluristratified epidermis: a preclinical study. Lancet. 2009;374:1745–1753.
    1. Kaiser HW, Stark GB, Kopp J, et al. Cultured autologous keratinocytes in fibrin glue suspension, exclusively and combined with STS-allograft (preliminary clinical and histological report of a new technique). Burns. 1994;20:23–29.
    1. Hartmann B, Ekkernkamp A, Johnen C, et al. Sprayed cultured epithelial autografts for deep dermal burns of the face and neck. Ann Plast Surg. 2007;58:70–73.
    1. Wood FM, Stoner ML, Fowler BV, et al. The use of a non-cultured autologous cell suspension and Integra dermal regeneration template to repair full-thickness skin wounds in a porcine model: a one-step process. Burns. 2007;33:693–700.
    1. Larouche D, Tong X, Fradette J, et al. Vibrissa hair bulge houses two populations of skin epithelial stem cells distinct by their keratin profile. FASEB J. 2008;22:1404.
    1. Schlabe J, Johnen C, Schwartlander R, et al. Isolation and culture of different epidermal and dermal cell types from human scalp suitable for the development of a therapeutical cell spray. Burns. 2008;34:376–384.
    1. McHeik JN, Barrault C, Bernard FX, et al. Quantitative and qualitative study in keratinocytes from foreskin in children: perspective application in paediatric burns. Burns. 2010;36:1277–1282.
    1. Kirsner RS, Marston WA, Snyder RJ, et al. Spray-applied cell therapy with human allogeneic fibroblasts and keratinocytes for the treatment of chronic venous leg ulcers: a Phase 2, multicentre, double blind, randomised, placebo-controlled trial. Lancet. 2012;12:60644–60648.
    1. Andreassi A, Bilenchi R, Biagioli M, et al. Classification and pathophysiology of skin grafts. Clin Dermatol. 2005;23:332–337.
    1. Tanner JC, Jr, Vandeput J, Olley JF. The mesh skin graft. Plast Reconstr Surg. 1964;34:287–292.
    1. Gabarro P. A new method of grafting. Br Med J. 1943;1:723–724.
    1. Zhang ML, Chang ZD, Han X, et al. Microskin grafting. I. Animal experiments. Burns Incl Therm Inj. 1986;12:540–543.
    1. Blair SD, Nanchahal J, Backhouse CM, et al. Microscopic split-skin grafts: a new technique for 30-fold expansion. Lancet. 1987;2:483–484.
    1. Inoue Y, Tanabe H, Tai Y. A method for the preparation of microskin grafts using skin-graft meshers. Plast Reconstr Surg. 1994;94:890.
    1. Kreis RW, Mackie DP, Hermans RP, et al. Expansion technique for skin grafts: comparison between mesh and Meek island (sandwiched-) grafts. Burns. 1994;20:39–42.
    1. Lai CS, Lin SD, Tsai CC, et al. An easy way to prepare microskin grafts. Burns. 1994;20:151–153.
    1. Hsieh CS, Schuong JY, Huang WS, et al. Five years’ experience of the modified Meek technique in the management of extensive burns. Burns. 2008;34:350–354.
    1. Lumenta DB, Kamolz LP, Frey M. Adult burn patients with more than 60% TBSA involved-Meek and other techniques to overcome restricted skin harvest availability—the Viennese Concept. J Burn Care Res. 2009;30:231–242.
    1. Guo F, Chen XL, Wang YJ, et al. Management of burns of over 80% of total body surface area: a comparative study. Burns. 2009;35:210–214.
    1. Chen XL, Liang X, Sun L, et al. Microskin autografting in the treatment of burns over 70% of total body surface area: 14 years of clinical experience. Burns. 2011;37:973–980.
    1. Rubis BA, Danikas D, Neumeister M, et al. The use of split-thickness dermal grafts to resurface full thickness skin defects. Burns. 2002;28:752–759.
    1. Querings K, Bachter D, Balda BR. Meshed reversed dermal graft in patients with surgical defects of sole and scalp: technique and long-term results. Dermatol Surg. 2002;28:122–126.
    1. Han SK, Yoon TH, Kim JB, et al. Dermis graft for wound coverage. Plast Reconstr Surg. 2007;120:166–172.
    1. Zakine G, Mimoun M, Pham J, et al. Reepithelialization from stem cells of hair follicles of dermal graft of the scalp in acute treatment of third-degree burns: first clinical and histologic study. Plast Reconstr Surg. 2012;130:42–50.
    1. Lindford AJ, Kaartinen IS, Virolainen S, et al. The dermis graft: another autologous option for acute burn wound coverage. Burns. 2012;38:274–282.
    1. Haslik W, Kamolz LP, Lumenta DB, et al. The treatment of deep dermal hand burns: how do we achieve better results? Should we use allogeneic keratinocytes or skin grafts? Burns. 2010;36:329–334.
    1. Gravante G, Di Fede MC, Araco A, et al. A randomized trial comparing ReCell system of epidermal cells delivery versus classic skin grafts for the treatment of deep partial thickness burns. Burns. 2007;33:966–972.
    1. Shukla VK, Tiwary SK, Barnwal S, et al. Effect of autologous epidermal cell suspension transplantation in chronic nonhealing wounds: a pilot study. Can J Surg. 2010;53:6–10.
    1. Mcheik JN, Barrault C, Pedretti N, et al. Foreskin-isolated kératinocytes provide successful extemporaneous autologous paediatric skin grafts. J Tissue Eng Regen Med. 2013 March 14 [Epub ahead of print]
    1. O’Connor N, Mulliken J, Banks-Schlegel S, et al. Grafting of burns with cultured epithelium prepared from autologous epidermal cells. Lancet. 1981;1:75–78.
    1. Donati L, Magliacani G, Bormioli M, et al. Clinical experiences with keratinocyte grafts. Burns. 1992;18:19–26.
    1. Bettex-Galland M, Slongo T, Hunziker T, et al. Use of cultured keratinocytes in the treatment of severe burns. Z Kinderchir. 1988;43:224–228.
    1. Langdon RC, Cuono CB, Birchall N, et al. Reconstitution of structure and cell function in human skin grafts derived from cryopreserved allogeneic dermis and autologous cultured keratinocytes. J Invest Dermatol. 1988;91:478–485.
    1. Compton CC, Hickerson W, Nadire K, et al. Acceleration of skin regeneration from cultured epithelial autografts by transplantation to homograft dermis. J Burn Care Rehabil. 1993;14:653–662.
    1. Carsin H, Ainaud P, Le Bever H, et al. Cultured epithelial autografts in extensive burn coverage of severely traumatized patients: a five year single-center experience with 30 patients. Burns. 2000;26:379–387.
    1. Sood R, Roggy D, Zieger M, et al. Cultured epithelial autografts for coverage of large burn wounds in eighty-eight patients: the Indiana University experience. J Burn Care Res. 2010;31:559–568.
    1. Still JM, Jr, Orlet HK, Law EJ. Use of cultured epidermal autografts in the treatment of large burns. Burns. 1994;20:539–541.
    1. Paddle-Ledinek JE, Cruickshank DG, Masterton JP. Skin replacement by cultured keratinocyte grafts: an Australian experience. Burns. 1997;23:204–211.
    1. Desai MH, Mlakar JM, McCauley RL, et al. Lack of long-term durability of cultured keratinocyte burn-wound coverage: a case report. J Burn Care Rehabil. 1991;12:540–545.
    1. Barret JP, Wolf SE, Desai MH, et al. Cost-efficacy of cultured epidermal autografts in massive pediatric burns. Ann Surg. 2000;231:869–876.
    1. Boyce ST, Kagan RJ, Greenhalgh DG, et al. Cultured skin substitutes reduce requirements for harvesting of skin autograft for closure of excised, full-thickness burns. J Trauma. 2006;60:821–829.
    1. Moustafa M, Bullock AJ, Creagh FM, et al. Randomized, controlled, single-blind study on use of autologous keratinocytes on a transfer dressing to treat nonhealing diabetic ulcers. Regen Med. 2007;2:887–902.
    1. Shevchenko RV, James SL, James SE. A review of tissue-engineered skin bioconstructs available for skin reconstruction. J R Soc Interface. 2010;7:229–258.
    1. Boyce ST, Goretsky MJ, Greenhalgh DG, et al. Comparative assessment of cultured skin substitutes and native skin autograft for treatment of full-thickness burns. Ann Surg. 1995;222:743–752.
    1. Sheridan RL, Morgan JR, Cusick JL, et al. Initial experience with a composite autologous skin substitute. Burns. 2001;27:421–424.
    1. Keck M, Haluza D, Lumenta DB, et al. Construction of a multi-layer skin substitute: simultaneous cultivation of keratinocytes and preadipocytes on a dermal template. Burns. 2011;37:626–630.
    1. Gómez C, Galán JM, Torrero V, et al. Use of an autologous bioengineered composite skin in extensive burns: clinical and functional outcomes. A multicentric study. Burns. 2011;37:580–589.
    1. Kirsner RS. The use of Apligraf in acute wounds. J Dermatol. 1998;25:805–811.
    1. Still J, Glat P, Silverstein P, et al. The use of a collagen sponge/living cell composite material to treat donor sites in burn patients. Burns. 2003;29:837–841.
    1. Gage FH. Cell therapy. Nature. 1998;392(6679 Suppl):18–24.
    1. De Corte P, Verween G, Verbeken G, et al. Feeder layer- and animal product-free culture of neonatal foreskin keratinocytes: improved performance, usability, quality and safety. Cell Tissue Bank. 2012;13:175–189.
    1. Clover AJ, O’Neill BL, Kumar AH. Analysis of attitudes toward the source of progenitor cells in tissue-engineered products for use in burns compared with other disease states. Wound Repair Regen. 2012;20:311–316.
    1. Stenn KS, Link R, Moellmann G, et al. Dispase, a neutral protease from Bacillus polymyxa, is a powerful fibronectinase and type IV collagenase. J Invest Dermatol. 1989;93:287–290.
    1. Adams JC, Watt FM. Changes in keratinocyte adhesion during terminal differentiation: reduction in fibronectin binding precedes alpha 5 beta 1 integrin loss from the cell surface. Cell. 1990;63:425–435.
    1. Morhenn VB, Benike CJ, Cox AJ, et al. Cultured human epidermal cells do not synthesize HLA-DR. J Invest Dermatol. 1982;78:32–37.
    1. Hefton JM, Amberson JB, Biozes DG, et al. Loss of HLA-DR expression by human epidermal cells after growth in culture. J Invest Dermatol. 1984;83:48–50.
    1. Brain A, Purkis P, Coates P, et al. Survival of cultured allogeneic keratinocytes transplanted to deep dermal bed assessed with probe specific for Y chromosome. BMJ. 1989;298:917–919.
    1. Pokorná E, Broz L, Veselý P, et al. Y chromosome and vimentin used to trace the fate of allogeneic keratinocytes delivered to the wound by the recombined human/pig skin. Folia Biol (Praha) 2001;47:128–134.
    1. Billingham RE, Reynolds J. Transplantation studies on sheets of pure epidermal epithelium and on epidermal cell suspensions. Br J Plast Surg. 1952;5:25–36.
    1. Hunyadi J, Farkas B, Bertényi C, et al. Keratinocyte grafting: a new means of transplantation for full-thickness wounds. J Dermatol Surg Oncol. 1988;14:75–78.
    1. Fraulin FO, Bahoric A, Harrop AR, et al. Autotransplantation of epithelial cells in the pig via an aerosol vehicle. J Burn Care Rehabil. 1998;19:337–345.
    1. Gerlach JC, Johnen C, McCoy E, et al. Autologous skin cell spray-transplantation for a deep dermal burn patient in an ambulant treatment room setting. Burns. 2011;37:19–23.
    1. Navarro FA, Stoner ML, Park CS, et al. Sprayed keratinocyte suspensions accelerate epidermal coverage in a porcine microwound model. J Burn Care Rehabil. 2000;21:513–518.
    1. Limat A, Noser FK. Serial cultivation of single keratinocytes from the outer root sheath of human scalp hair follicles. J Invest Dermatol. 1986;87:485–488.
    1. Taylor G, Lehrer MS, Jensen PJ, et al. Involvement of follicular stem cells in forming not only the follicle but also the epidermis. Cell. 2000;102:451–461.
    1. Blanpain C, Horsley V, Fuchs E. Epithelial stem cells: turning over new leaves. Cell. 2007;128:445–458.
    1. Lavoie A, Fugère C, Fradette J, et al. Considerations in the choice of a skin donor site for harvesting keratinocytes containing a high proportion of stem cells for culture in vitro. Burns. 2011;37:440–447.
    1. Mcheik JN, Barrault C, Vincent G, et al. Modèles de cultures cellulaires kératinocytaires de prépuce. Possibilité d’application chez les enfants brûlés. Ann Chir Plast Esthet. 2009;54:528–532.
    1. Uitto J. Regenerative medicine for skin diseases: iPS cells to the rescue. J Invest Dermatol. 2011;131:812–814.
    1. Pham C, Greenwood J, Cleland H, et al. Bioengineered skin substitutes for the management of burns: a systematic review. Burns. 2007;33:946–957.
    1. Mulekar SV, Ghwish B, Al Issa A, et al. Treatment of vitiligo lesions by ReCell vs. conventional melanocyte-keratinocyte transplantation: a pilot study. Br J Dermatol. 2008;158:45–49.
    1. Cervelli V, De Angelis B, Spallone D, et al. Use of a novel autologous cell-harvesting device to promote epithelialization and enhance appropriate pigmentation in scar reconstruction. Clin Exp Dermatol. 2009;35:776–780.

Source: PubMed

Sponsoren und Mitarbeiter

Krankheiten

Drogeninterventionen

3
Abonnieren